The discovery of the (pro)renin receptor (PRR) by Ngyuen et al. (1) came at a time in the field of hypertension and cardiovascular disease when the search was on for a new therapeutic target of the renin-angiotensin-system (RAS). The gene discussed is ATP6AP2; the disease is cardiovascular disorder.